These cells, known as cancer stem cells (CSC) or tumor initiating cells, possibly originate from non-malignant stem cells or progenitor cells, with which they share several characteristics, including the expression of stem cell markers such as SOX2, NANOG, CD133, and CD44. This evidence concerns the gene NANOG and neoplasm.